Zylö Therapeutics receives $300K investment from SC Launch

▤ Summary

SC Launch Inc., South Carolina Research Authority (SCRA’s) investment affiliate, announced Dec. 7 it has invested $300,000 in Zylö Therapeutics Inc., a medical research business in Greenville. “The list of health care conditions to be treated by Zylö’s developments continues to grow,” said SCRA executive director Bob Quinn. “They are pursuing solutions to help patients with lupus, hair loss, joint pain, and even burns, just to name a few. Their commitment to innovative treatment discoveries have set them on a path of continued growth and success. We’d excited to have them in our portfolio of companies.” Zylö Therapeutics joined SCRA in 2018 and has received a variety of funding:

▦ Linked Companies